Company news
Bioadaptives, Inc. (OTC:BDPT) news
Bioadaptives, Inc. news releases on 6ix. Latest, Sep 23, 2026: BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video
Press releases & updates
BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video
September 23, 2026
BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress
September 3, 2026
UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM)
August 31, 2026
BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update
August 13, 2026
BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal
August 12, 2026
BioAdaptives Explains the Scientific Basis of the Dual-Action Xcellara(TM) "Supply and Direction" Platform
August 4, 2026
BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula
August 3, 2026
BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor
July 30, 2026
BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform
July 29, 2026
BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
July 23, 2026
BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness
July 16, 2026
BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells
July 15, 2026
BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
June 25, 2026
BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
May 20, 2026
BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
May 6, 2026
BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
April 28, 2026
BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing
October 7, 2025
BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety
August 20, 2025
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
July 16, 2025
BioAdaptives Announces National Launch of Pawpa™ Regen
June 24, 2025
BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements
May 28, 2025
Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial
March 12, 2025
BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors
February 5, 2025
BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors
February 2, 2025
BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders
January 20, 2025
BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health
December 9, 2024
BioAdaptives, Inc. Establishes a Wholesale Division to Expand Marketing Presence in a USD 151.9 Billion Global Dietary Supplement Market
December 8, 2022
BioAdaptives, Inc. Announces TizHemp, a New Hemp-Product Division, & Appointment of New CFO
September 24, 2019
BioAdaptives, Inc. Announces Return to Fully Reporting and Appointment of President
September 11, 2019